The American Food and Drug Administration (FDA), which previously reported that J&J vaccines were safe and effective, accepted that vaccine studies were insufficient. Scientists criticize the FDA for declaring that the vaccine is safe despite insufficient data.
The US Food and Drug Administration, the coronavirus vaccine developed by the pharmaceutical company Johnson and Johnson “safe and effective” and against the virus 66% protection had reported. The scientists reported that the data presented in the panel about the J&J vaccine “insufficient” He claimed it was approved though.
J&J submitted vaccine analysis data to the Food and Drug Administration 10 days before the Vaccines and Related Biologicals Advisory Committee meeting. All the data presented by the authorities J&J on the criticism of scientists they haven’t confirmed yet he accepted.
threatens public health
Committee member Dr. Michael Nelson’s J&J data that it is insufficient but to support emergency use in the United States of the safety and efficacy data provided. is enough you think told. Director of the FDA’s Center for Biological Research, Dr. Peter Marks reported that data on the J&J vaccine will take months to complete, and his investigations will continue throughout the process.
RELATED NEWS
Production of COVID-19 Vaccines Badly Affects Mixed Vaccine Production: Pet Losses Increase
According to these results, the booster showed less side effects than the first dose, Dr. Vaccine studies by Timothy Brennan insufficient said that. A valid result was obtained on the grounds that there were only 17 participants between the ages of 18-55 in the study. He stressed that it is not possible. Committee Chairman Dr. Arnold Monto stated that J&J’s rapid review efforts have resulted in poorer performance compared to Pfizer and Moderna vaccines. On public health information about J&J vaccines, which have a lower efficacy than other vaccines posing a threat and stated that it is necessary to hurry to fix something.
Source :
https://www.cnbc.com/2021/10/15/scientists-question-fda-on-scant-jj-booster-data-and-speedy-review.html